A Review: Epidemiology and Risk Factors of Lung Cancer patients in Thailand

Authors

  • Ananya Sirisomboon Satriwithaya School, Bangkok
  • Gwinlada Tayanun Demonstration School of Phranakhon Si Ayutthaya Rajabhat University, Phranakhon Si Ayutthaya
  • Nithikorn Tanskul Bangkok International Preparatory
  • Surangpimol Puedtapongpaphanij Assumption College Sriracha, Bangkok
  • Thanique Sirisoonthornphibul Chulalongkorn University Demonstration Secondary School, Bangkok
  • Chottanin Teerakomolwit Mahidol University International Demonstration School, Bangkok
  • Justin Chatpaisankun Nakhon Sawan School, Nakhon Sawan

Keywords:

Lung cancer epidemiology, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC)

Abstract

Lung cancer is a prominent cause of cancer-related mortality globally, with increasing incidence and mortality rates in Thailand. This review delves into the epidemiology and risk factors associated with Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC) in Thailand. In 2021, lung cancer accounted for 17.9% of all cancer-related deaths, with a rising trend in incidence observed between 2012 and 2022. SCLC, characterized by its aggressive nature, constituted 4.5% of all lung cancer cases in Thailand between 2016 and 2021. Notably fatal, SCLC exhibited a higher mortality rate than NSCLC, with distinct survival rates in limited and extensive stages. NSCLC, comprising various subtypes, dominated the lung cancer landscape in Thailand, with adenocarcinoma being the most prevalent.

The review emphasizes smoking as a primary risk factor for lung cancer, despite a decline in smoking prevalence. Radon exposure, especially in upper-northern Thailand, emerges as a significant contributor to lung cancer incidence, with a notable proportion of deaths linked to indoor radon exposure. Additionally, air pollution, characterized by PM 2.5 and other pollutants, is implicated in lung cancer development, mirroring global trends.

This comprehensive review underscores the critical need for targeted interventions to address the rising burden of lung cancer in Thailand. Efforts should focus on smoking cessation programs, radon exposure mitigation, and air quality improvement to curb the escalating rates of lung cancer and enhance public health outcomes. Ongoing research and surveillance are crucial for refining preventive strategies and advancing our understanding of the complex interplay between environmental factors and lung cancer in the Thai population.

References

Basumallik, N. & Agarwal, M. (2023). Small Cell Lung Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing.

Benjakul, N., Laohathai, S. & Supakatitham, C. (2022). Clinical Characteristics and Pathologic Profiles Correlation of Primary Lung Cancer: A 6-Year Retrospective Study in Thailand’s Metropolitan Medical Center. Vajira Medical Journal: Journal of Urban Medicine, 66(1), 1-10.

Chang, J.T., Jeon, J., Sriplung, H., Yeesoonsang, S., Bilheem S, Rozek L, & Meza, R. (2018). Temporal Trends and Geographic Patterns of Lung Cancer Incidence by Histology in Thailand, 1990 to 2014. Journal of Global Oncology, 4, (4)157-169.

Chhikara, B.S. & Parang, K. (2023). Global Cancer Statistics 2022: the trends projection analysis. Chemical Biology Letters, 10(1), 451.

Clark, S.B. & Alsubait, S. (2023). Non–Small Cell Lung Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing

Eckel, S.P., Cockburn, M., Shu, Y.H., Deng, H., Lurmann, F.W., Liu, L. & Gilliland, F.D. (2016). Air pollution affects lung cancer survival. Thorax, 71(10), 891-898.

Fan, H., Shao, Z., Xiao, Y., Xie, Z., Chen, W., Xie, H., & Zhao, N.Q. (2015). Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study. BMJ Open, 5(12), e009419.

Ganti, A.K., Klein, A.B., Cotarla, I., Seal, M. & Chou, E. (2021). Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients with Non–Small Cell Lung Cancer in the US. JAMA Oncol, 7(12), 1–9.

Gaskin, J., Coyle, D., Whyte, J. & Krewksi, D. (2018). Global estimate of lung cancer mortality attributable to residential radon. Environ. Health Perspect, 126(5), 057009

Hecht, S.S. (2012). Lung Carcinogenesis by Tobacco Smoke. Int J Cancer, 131(12), 2724-2732.

Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K. & Swanton, C. (2023). Lung adenocarcinoma promotion by air pollutants. Nature, 616(7955), 159–167

Huang J, Deng Y, Tin MS, Lok V, Ngai CH, Zhang L, & Wong, M.C.S. (2022). Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality: A Global Analysis. Chest, 161(4), 1101-1111.

Huang, J., Ngai, C. H., Deng, Y., Tin, M. S., Lok, V., Zhang, L., … Wong, M. C. S. (2022). Cancer Incidence and Mortality in Asian Countries: A Trend Analysis. Cancer control: journal of the Moffitt Cancer Center, 29, 10732748221095955

IARC. (2004). Tobacco Smoke and Involuntary Smoking. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 83. Lyon (FR): International Agency for Research on Cancer.

International atomic energy agency. (2013). National and Regional Surveys of Radon Concentration in Dwellings. In: IAEA Analytical Quality in Nuclear Applications Series No. 33. Vienna: IAEA

International Agency for Research on Cancer. (2022). The Global Cancer Observatory Thailand. Lyon, France: International Agency for Research on Cancer

Kittiwarawut, A. & Bunthaowong, P. (2014). Lung cancer in Prapokklao Hospital. J Prapokklao Hosp Clin Med Educat Center, 31(4), 248-265.

Lamichhane, D.K., Kim, H.C., Choi, C.M., Shin, M.H., Shim, Y.M., Leem, J.H & Park, S.M. (2017). Lung Cancer Risk and Residential Exposure to Air Pollution: A Korean Population-Based Case-Control Study. Yonsei Med J, 58(6), 1111-1118.

Malhotra, J., Malvezzi, M., Negri, E., La Vecchia, C. & Boffetta, P. (2016). Risk factors for lung cancer worldwide. Eur Respir J, 48(3), 889-902.

Molina, J.R., Yang, P., Cassivi, S.D., Schild, S.E. & Adjei, A.A. (2008). Non–Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clin Proc., 83(5), 584-594.

Mullangi, S. & Lekkala, M.R. (2024). Adenocarcinoma. Treasure Island (FL): StatPearls Publishing.

Murphy, S.E., von Weymarn, L.B., Schutten, M.M., Kassie, F. & Modiano, J.F. (2011). Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis. Cancer Prev Res (Phila), 4(11), 1752-1760.

Musika, M., Kamsa-ard, S., Jirapornkul, C., Santong, C. & Phunmanee, A. (2021). Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017). Asian Pac J Cancer Prev, 22(8), 2501-2507.

National Cancer Institute (Thailand). (2018). National Cancer Control Programme (2018-2022). Bangkok, Thailand: National Cancer Institute.

Pallis, A.G. & Syrigos, K.N. (2013). Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol, 88(3), 494-503.

Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin & DGoldman, J.W. (2019). Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet, 394(10212), 1929-1939.

PDQ Adult Treatment Editorial Board. (2002). Non-Small Cell Lung Cancer Treatment (PDQ®): Health Professional Version. In: PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US)

Pongnikorn, D., Daoprasert, K., Wongkaew, B., Sangkam, S., Praditkay, M. & Meemark, R. (2020). Trends in Cancer Incidence and Mortality in Northern Thailand, 1993-2017. LPCH Cancer Registry Publication No.38.

Reitsma, M.B., Flor, L.S., Mullany, E.C., Gupta, V., Hay, S.I. & Gakidou, E. (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990–2019. Lancet Public Health, 6(7), e472-e481.

Reungwetwattana, T., Oranratnachai, S., Puataweepong, P., Tangsujaritvijit, V. & Cherntanomwong, P. (2020). Lung Cancer in Thailand. Journal of Thoracic Oncology, 15(1), 1714-1721.

Riudavets, M., Garcia de Herreros, M., Besse, B. & Mezquita, L. (2022). Radon and Lung Cancer: Current Trends and Future Perspectives. Cancers (Basel), 14(13), 3142.

Rodríguez-Martínez, Á., Torres-Durán, M., Barros-Dios, J.M. & Ruano-Ravina, A. (2018). Residential radon and small cell lung cancer. A systematic review. Cancer Letters, 426, 57-62

Rodríguez-Martínez, Á., Ruano-Ravina, A., Torres-Durán, M., Provencio, M., Parente-Lamelas, I., Vidal-García, I. & Pérez-Ríos, M. (2022). Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study. Arch Bronconeumol, 58(7), 542-546.

Ruano-Ravina, A., Torres-Durán, M., Kelsey, K.T., Parente-Lamelas, I., Leiro-Fernández, V., Abdulkader, I. & Barros-Dios, J.M. (2016). Residential radon EGFR mutations and ALK alterations in never-smoking lung cancer cases. Eur Respir J, 48, 1462-1470.

Ruano-Ravina A, Faraldo-Valles MJ & Barros-Dios JM. (2009). Is there a specific mutation of p53 gene due to radon exposure? A systematic review. Int J Radiat Biol, 85(7), 614-621.

Rudin, C.M., Brambilla, E., Faivre-Finn, C. & Sage, J. (2021). Small-cell lung cancer. Nat Rev Dis Primers, 7(1), 3.

Siddiqui, F., Vaqar, S. & Siddiqui, A.H. (2023). Lung Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing.

Somsunun, K., Prapamontol, T., Pothirat, C., Liwsrisakun, C., Pongnikorn, D., Fongmoon D., & Tokonami, S. (2022). Estimation of lung cancer deaths attributable to indoor radon exposure in upper northern Thailand. Sci Rep, 12, 5169.

Supasri, T., Gheewala, S.H., Macatangay, R., Chakpor, A. & Sedpho S. (2023). Association between ambient air particulate matter and human health impacts in northern Thailand. Sci Rep, 13, 12753.

Supavavej, A., Sungkasubun, P., Siripaibun, J., Chaiwiriyawong, W., Chavanisakun, C., Sricharunrat, T. & Lamlertthon, W. (2021). The Prevalence of Adenocarcinoma in Non-small Cell Lung Cancer Patients at Chulabhorn Hospital. J Med Assoc Thai, 104(7), 1-4.

Thandra, K.C., Barsouk, A., Saginala, K., Aluru, J.S. & Barsouk, A. (2021). Epidemiology of lung cancer. Contemp Oncol (Pozn), 25(1), 45–52.

Vichapat, V., Chantasartrassamee, P. & Reungwetwattana, T. (2023). Impact of Waiting Times on Mortality in Advanced Stage Non-Small Cell Lung Cancer: A 10-Year Retrospective Cohort Study in Thailand. Asian Pacific journal of cancer prevention: APJCP, 24(10), 3419–3428.

Virani, S., Bilheem, S., Chansaard, W., Chitapanarux, I., Daoprasert, K., Khuanchana, S. &Sriplung, H. (2017). National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest Burdens. Cancers (Basel), 9(8), 108.

World Health Organization. (2009). WHO handbook on indoor radon: A public health perspective. Geneva: World Health Organization.

Wang, W., Liu, H. & Li, G. (2022). What’s the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients. Front. Endocrinol. 13:947443.

Wu, X.Q., Li, J.Y. & Du, W.J. (2022). Causes of death following small cell lung cancer diagnosis: a population-based analysis. BMC Pulm Med, 22(1), 262.

Yaser, A., Haijun, Z., Fan, F., Jing C. & Baoan, C. (2023). Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment. Medicine, 102(8), e32899.

Yin, X., Chan, C.P.Y., Seow, A., Yau, W.P. & Seow, W.J. (2021). Association between family history and lung cancer risk among Chinese women in Singapore. Sci Rep, 11(1), 21862.

Downloads

Published

2024-08-31

How to Cite

Sirisomboon, A., Tayanun, G. ., Tanskul, N. ., Puedtapongpaphanij, S. ., Sirisoonthornphibul, T. ., Teerakomolwit, C. ., & Chatpaisankun, J. . (2024). A Review: Epidemiology and Risk Factors of Lung Cancer patients in Thailand. SciTech Research Journal, 7(2), 155–168. Retrieved from https://ph02.tci-thaijo.org/index.php/jstrmu/article/view/253034

Issue

Section

Academic Article